Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-β1a (IFN-β1a), 22 μg subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-β1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS
SPECTRIMS Study Group.Randomized controlled trial ofl interfleron-beta-1a in secondary progressive MS: clinical results . Neurology2001; 56: 1496-504 .
3.
Benito-Leon J. , Morales JM , Rivera-Navarros J. , Mitchell AJA review about the impact ofl multiple sclerosis on health-related quality ofl lifle . Disabil Rehabil2003; 25: 1291-303 .
4.
Fruehwald S. , Loeffler-Stastka H. , Eher R. , Saletu B. , Baumhackl U.Depression and quality ofl lifle in multiple sclerosis . Acta Neurol Scand2001; 104: 257-61 .
5.
Benedict Rhb , Wahlig E. , Bakshi R. , Fishman I. , Munschauer F. , Zivadinov R. et al. Predicting quality ofl lifle in multiple sclerosis: accounting flor physical disability, flatigue, cognition, mood disorder, personality, and behaviour change . J Neurol Sci2005; 231: 29-34 .
6.
Mitchell AJ , Benito-Leon J. , Gonzales J-MM , Rivera-Navarro J.Quality ofl lifle and its assessment in multiple sclerosis: integrating physical and psychological components ofl wellbeing . Lancet Neurol2005; 4: 556-66 .
7.
Merkelbach S. , Sittinger H. , Koenig J.Is there a diflflerential impact ofl flatigue and physical disability on quality ofl lifle in multiple sclerosis?J Nerv Ment Dis2002; 190: 388-93 .
8.
Weinshenker BG , Penman M. , Bass B. , Ebers GC , Rice Gpa.A double-blind, randomized crossover trial ofl pemoline in flatigue associated with multiple sclerosis . Neurology1992; 42: 1468-71 .
9.
Freal JE , Kraft GH , Coryell JKSymptomatic flatigue in multiple sclerosis . Arch Phys Med Rehabil1984; 65: 135-38 .
10.
Fisk J. , Ritvo PG , Ross L. , Haase DA , Marrie TJ , Schlech WFMeasuring the flunctional impact ofl flatigue: initial validation ofl the Fatigue Impact Scale . Clin Inf Dis1994; 18: 79-83 .
11.
Beiske A. , Pedersen ED , Czujko B. , Myhr K-M.Pain and sensory complaints in multiple sclerosis . Eur J Neurol2004; 11: 479-82 .
12.
Nortvedt MW , Riise T. , Myhr KM , Nyland HIQuality ofl lifle as a predictor flor change in disability in MS . Neurology2000; 55: 51-54 .
13.
Visschedijk Maj , Uitdehaag Mbj , Klein M. , van der Ploeg E. , Collette EH , Vleugels L. et al. Value ofl healthrelated quality ofl lifle to predict disability course in multiple sclerosis . Neurology2004; 63: 2046-50 .
14.
Freeman JA , Thompson AJ , Fitzpatrick R. , Hutchinson M. , Miltenburger C. , Beckmann K. et al. Interfleron-beta 1b in the treatment ofl secondary progressive MS. Impact on quality ofl lifle . Neurology2001; 57: 1870-75 .
15.
Cohen JA , Cutter GR , Fischer JS , Goodman Ad , Heidenreich FR , Kooijmans MF et al. Benefit ofl interfleron beta-1a on MSFC progression in secondary progressive MS . Neurology2002; 59: 679-87 .
16.
Hunt SM , McKenna SP , McEwen J. , Williams J. , Papp E.The Nottingham Health Profile: subjective health status and medical consultations . Soc Sci Med1981; 15A: 221-29 .
17.
Jenkinson C. , Fitzpatrick R. , Argyle M.The Nottingham Health Profile: an analysis ofl its sensitivity in diflflerentiating illness groups . Soc Sci Med1998; 27: 1411-14 .
18.
Andersen O. , Elovaara I. , Farkkila M. , Hansen HJ , Mellgren, Myhr KM et al. Multicentre, randomised, double blind, placebo controlled, phase III study ofl weekly, low dose, subcutaneous interfleron beta-1a in secondary progressive multiple sclerosis . J Neurol NeurosurgPsychiatry2004; 75: 706-10 .
19.
Poser CM , Paty DW , Scheinberg L. , McDonald I. , Davis FA , Ebers GC et al. New diagnostic criteria flor multiple sclerosis: guidelines flor research protocols . Ann Neurol1983; 13: 227-31 .
20.
Kurtzke JFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology1983; 33: 1444-52 .
21.
Barnes D. , Hughes Rac , Morris RW , Wade-Jones O. , Brown P. , Britton T. et al. Randomised trial ofl oral and intravenous methylprednisolone in acute relapses ofl multiple sclerosis . Lancet1997; 349: 902-906 .
22.
Weiner HL , Mackin GA , Orav EJ , Hafler DA , Dawson DM , LaPierre Y. et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report ofl the Northeast Cooperative Multiple Sclerosis Treatment Group . Neurology1993; 43: 910-18 .
23.
Grant S. , Aitchison T. , Henderson E. , Christie J. , Zare S. , McMurray J. et al. A comparison ofl the reproducibility and the sensitivity to change ofl visual analog scales, Borg scales, and Likert scales in normal subjects during submaximal exercise . Chest2001; 116: 1208-17 .
24.
Hunt SM , Wicklund I.Cross-cultural variation in the weighting ofl health statements: a comparison ofl English and Swedish valuations . Health Policy1987; 8: 227-35 .
25.
Wicklund I. , Romanus B. , Hunt SMSelfl-assessed disability in patients with arthrosis ofl the hip joint. Reliability ofl the Swedish version ofl the Nottingham Health Profile . Int Disabil Stud1988; 10: 159-63 .
26.
Nortvedt MW , Riise T. , Myhr K-M. , Nyland HIQuality ofl lifle in multiple sclerosis. Measuring the disease eflflects more broadly . Neurology1999; 53: 1098-103 .
27.
Canadian Burden of Illness Study Group.Burden ofl illness ofl multiple sclerosis. Part II: Quality ofl lifle . Can J Neurol Sci1998; 25: 31-38 .
28.
Murphy N. , Confavreaux C. , Haas J. , König N. , Roullet E. , Sailer M. et al. Quality ofl lifle in multiple sclerosis in France, Germany, and the United Kingdom . J Neurol Neurosurg Psychiatry1998; 65: 460-66 .
29.
Schwartz L. , Kraft GHThe role ofl spouse responses to disability and flamily environment in multiple sclerosis . Am J Phys Med Rehabil1999; 78: 525-32 .
30.
Solari A. , Palmisano L. , Mendozzi L. , Ghezzi A. , Mosconi P. , Pozzilli C.The impact ofl multiple sclerosis on health-related quality ofl lifle . Neurology1999; 52: A141 .
31.
Nicholl CR , Lincoln NB , Francis VM , Stephan TFAssessing quality ofl lifle in people with multiple sclerosis . Disabil Rehabil2001; 23: 597-603 .
32.
Rotstein Z. , Barak Y. , Noy S. , Achiron A.Quality ofl lifle in multiple sclerosis: development and validation ofl the ``RAYS'' scale and comparison with the SF-36 . Int J Qual Health Care2000; 12: 511-17 .
33.
McCabe MP , McKern S.Quality ofl lifle and multiple sclerosis: comparison between people with multiple sclerosis and people flrom the general population . J Clin Psychol2002; 9: 287-95 .
34.
Janssens Acjw , van Dorn PA , de Boer JB , van der Meché Fga , Passchier J. , Hintzen RQImpact ofl recently diagnosed multiple sclerosis on quality ofl lifle, anxiety, depression and distress ofl patients and partners . Acta Neurol Scand2003; 108: 389-95 .
35.
Patti F. , Cacopardo M. , Palermo F. , Ciancio MR , Lopes R. , Restivo D. et al. Health-related quality ofl lifle and depression in an Italian sample ofl multiple sclerosis patients . J Neurol Sci2003; 211: 55-62 .
36.
Isaksson AK , Ahlstrøm G. , Gunnarsson LGQuality ofl lifle and impairment in patients with multiple sclerosis . J Neurol Neurosurg Psychiatry2005; 76: 64-69 .
37.
Freeman JA , Langdon DW , Hobart JC , Thompson AJInpatient rehabilitation in multiple sclerosis. Do the benefits carry over into the community?Neurology1999; 52: 50-56 .
38.
Rudick RA , Miller D. , Clough JD , Gragg LA , Farmer G.Quality ofl lifle in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis . Arch Neurol1992; 49: 1237-42 .
39.
Sprangers Mag , de Regt EB , Andries F. , van Agt Hme , Bijl RV , de Boer JB et al. Which chronic conditions are associated with better or poorer quality ofl lifle ? J Clin Epidemiol2000; 53: 895-907 .
40.
Pfennings L. , Cohen L. , Herman A. , Polman C. , Lankhorst G. , Smits R. et al. Exploring diflflerences between subgroups ofl multiple sclerosis patients in health-related quality ofl lifle . J Neurol1999; 246: 587-91 .
41.
Shawaryn MA , Schiaffino KM , LaRocca NG , Johnston MVDeterminants ofl health-related quality ofl lifle in multiple sclerosis: the role ofl illness intrusiveness . Mult Scler2002; 8: 310-18 .
42.
Zivadinov R. , Zorzon M. , Tommasi MA , Nasuelli D. , Bernardi M. , Monti-Bragadin L. et al. A longitudinal study ofl quality ofl lifle and side eflflects in patients with multiple sclerosis treated with interfleron beta-1a . J Neurol Sci2003; 216: 113-18 .
43.
Janardhan V. , Bakshi R.Quality ofl lifle in patients with multiple sclerosis: the impact ofl flatigue and depression . J Neurol Sci2002; 205: 51-58 .
44.
Loge JH , Kaasa S. ShortForm (SF-36) health survey: normative data flrom the general Norwegian population . Scand J Soc Med1998; 26: 250-58 .
45.
Sullivan M. , Karlsson J.The Swedish SF-36 Health Survey-III. Evaluation ofl criterion-based validity: results flrom normative population . J Clin Epidemiol1998; 51: 1105-13 .
46.
Moulin DE , Foley KM , Ebers GCPain syndromes in multiple sclerosis . Neurology1998; 38: 1830-34 .
47.
Stenager E. , Knutsen L. , Jensen K.Acute and chronic pain syndromes in multiple sclerosis . Acta Neurol Scand1991; 84: 197-200 .
48.
Pittock SJ , Mayr WT , McClelland RL , Jorgens NW , Weigand SD , Noseworthy JH et al. Quality ofl lifle is flavourable flor most patients with multiple sclerosis . Arch Neurol2004; 61: 679-86 .
Ford HL , Gerry E. , Johnson MH , Tennant A.Health status and quality ofl lifle ofl people with multiple sclerosis . Disabil Rehabil2001; 23: 516-21 .
51.
Katschnig H.How useflul is the concept ofl quality ofl lifle in psychiatry ? Curr Opin Psychiatry1997; 10: 337-45 .
52.
Tachibana N. , Howard RS , Hirsch NP , Miller DH , Moseley IF , Fish D.Sleep problems in multiple sclerosis . Eur J Neurol1994; 34: 320-23 .
53.
Fleming WE , Pollak CPSleep disorders in multiple sclerosis . Semin Neurol2005; 25: 64-68 .
54.
Pakenham KIAdjustment to multiple sclerosis: application ofl a stress and coping model . Health Psychol1999; 18: 383-92 .
55.
Vickrey BG , Hays RD , Harooni R. , Myers LW , Ellison GWA health-related quality ofl lifle measure flor multiple sclerosis . Qual Life Res1995; 4: 187-206 .
56.
Vermersch P. , de Seze J. , Delisse B. , Lemaire S. , Stojkovic T.Quality ofl lifle in multiple sclerosis: influence ofl interfleron-beta 1a (Avonex) treatment . Mult Scler2002; 8: 377-81 .
57.
Gruenewald DA , Higginson IJ , Vivat B. , Edmonds P. , Burman REQuality ofl lifle measures flor the palliative care ofl people severely aflflected by multiple sclerosis: a systematic review . MultScler2001; 10: 690-704 .
58.
Rothwell PM , McDowell Z. , Wong CK , Dorman PJDoctors and patients don't agree: cross sectional study ofl patients' and doctors' perceptions and assessments ofl disability in multiple sclerosis . BMJ1997; 314: 1580-83 .
59.
Gold SM , Schulz H. , Mønch A. , Schulz K-H. , Heesen C.Cognitive impairment in multiple sclerosis does not aflflect reliability and validity ofl selfl-report health measures . Mult Scler2001; 9: 404-10 .
60.
Marrie RA , Miller DM , Chelune GJ , Cohen JAValidity and reliability ofl the MSQLI in cognitively impaired patients with multiple sclerosis . Mult Scler2003; 9: 621-26 .
61.
Moore F. , Wolfson C. , Alexandrov L. , Lapierre Y.Do general and multiple sclerosis-specific quality ofl lifle instruments diflfler ? Can J Neurol Sci2004; 31: 64-71 .
62.
Stolee P. , Zaza C. , Pedlar A. , Myers AMAn individualised approach to outcome measurement in geriatric rehabilitation . J Gerontol Ser A Bio Sci Med Sci1999; 54: 641-47 .
63.
LaChapelle Dl , Finlayson MAAn evaluation ofl subjective and objective measures ofl flatigue in patients with brain injury and healthy controls . Brain Inj1998; 12: 649-59 .
